Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Cardiac Pacemakers, Inc.

This article was originally published in The Gray Sheet

Executive Summary

Cardiac Pacemakers, Inc.: Guidant unit plans to begin shipments of its Vigor DR and SR adaptive rate pulse generators the week of June 26 following receipt of FDA premarket approval. The dual-chamber DR will list for $7,295 while the single-chamber SR will sell for $6,295, the firm says. The pacer systems "use an advanced accelerometer technology to monitor the patient's physical activity and provide rate modulation to meet the patient's needs." FDA's Circulatory System Devices Panel unanimously recommended approval of the products May 9 ("The Gray Sheet" May 15, p. 10)...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT004287

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel